← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
A-Alpha Bio, Inc.
Seattle, WA
$1,651,453
Total funding
3
Grants
Funding over time
peak $1.4M · FY2018–20$2M$1.5M$1M$500K$0
'18
'19
'20
Funding mix
By agency
NSF$1,651,453 · 3
By mechanism
—$1,651,453 · 3
Investigators at A-Alpha Bio, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
SBIR Phase II: Developing a Platform for Multiplexed Drug Profiling Using Yeast Synthetic Agglutination$1,170,453
· FY2020 · TIP
SBIR Phase I: Developing a Rapid Antibody Generation Platform for Emerging COVID-19 Variants$256,000
· FY2020 · TIP
SBIR Phase I: Developing a Platform for Multiplexed Drug Profiling Using Yeast Synthetic Agglutination$225,000
· FY2018 · TIP